Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease
Chagas disease, caused by the <i>Trypanosoma cruzi</i> parasitic protozoan, is a neglected tropical disease (NTD) of significant incidence in Latin America. Transmission to humans and other mammals is mainly via the vector insect from the Reduviidae family, popularly known as the kissing...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | Diogo de Freitas Paiva, Ana Paula dos Santos Matos, Denise de Abreu Garófalo, Tatielle do Nascimento, Mariana Sato de Souza de Bustamante Monteiro, Ralph Santos-Oliveira, Eduardo Ricci-Junior |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/16/8/1163 |
Similar Items
Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models
by: Lorraine Martins Rocha Orlando, et al.
Published: (2023-09-01)
by: Lorraine Martins Rocha Orlando, et al.
Published: (2023-09-01)
Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
by: Jean-Yves Brossas, et al.
Published: (2021-11-01)
by: Jean-Yves Brossas, et al.
Published: (2021-11-01)
An Update on Vaccines Against <i>Trypanosoma cruzi</i> and Chagas Disease
by: Nisha J. Garg
Published: (2025-01-01)
by: Nisha J. Garg
Published: (2025-01-01)
Chagas, a lógica e a descoberta Chagas, the logic and the discovery
by: François Delaporte
Published: (1995-02-01)
by: François Delaporte
Published: (1995-02-01)
In Vitro Antioxidant and Antitrypanosomal Activities of Extract and Fractions of <i>Terminalia catappa</i>
by: Sandra Alves de Araújo, et al.
Published: (2023-06-01)
by: Sandra Alves de Araújo, et al.
Published: (2023-06-01)
Antitrypanosomal Activity of Novel Benzaldehyde-Thiosemicarbazone Derivatives from Kaurenoic Acid †
by: Cecília M. A. de Oliveira, et al.
Published: (2011-01-01)
by: Cecília M. A. de Oliveira, et al.
Published: (2011-01-01)
Challenges in Chagas Disease Drug Development
by: Amanda F. Francisco, et al.
Published: (2020-06-01)
by: Amanda F. Francisco, et al.
Published: (2020-06-01)
Chagas Disease in People with HIV: A Narrative Review
by: Eva H. Clark, et al.
Published: (2021-11-01)
by: Eva H. Clark, et al.
Published: (2021-11-01)
What Do You Need to Know before Studying Chagas Disease? A Beginner’s Guide
by: José A. De Fuentes-Vicente, et al.
Published: (2023-07-01)
by: José A. De Fuentes-Vicente, et al.
Published: (2023-07-01)
An experimental and clinical assay with ketoconazole in the treatment of Chagas disease
by: Zigman Brener, et al.
Published: (1993-03-01)
by: Zigman Brener, et al.
Published: (1993-03-01)
Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al.
by: Andrei Fornanciari Antunes, et al.
Contribuciones de la genética y la proteómica al estudio de la enfermedad de Chagas Genomic and proteomic contributions for Chagas disease control
by: Teresa López-Ordóñez, et al.
Published: (2009-01-01)
by: Teresa López-Ordóñez, et al.
Published: (2009-01-01)
Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease
by: Bruno Lisboa Timm, et al.
Published: (2023-05-01)
by: Bruno Lisboa Timm, et al.
Published: (2023-05-01)
New evidence of spontaneous cure in human Chagas' disease Novas evidências da cura espontânea da doença de Chagas humana
by: Sonia S. Francolino, et al.
Published: (2003-01-01)
by: Sonia S. Francolino, et al.
Published: (2003-01-01)
Immunopathology of cardiomyopathy in the experimental Chagas disease
by: Milena BP Soares, et al.
Published: (1999-09-01)
by: Milena BP Soares, et al.
Published: (1999-09-01)
Chagas Disease in Pregnant Women from Endemic Regions Attending the Hospital General de Mexico, Mexico City
by: Indira Chakravarti, et al.
Published: (2022-01-01)
by: Indira Chakravarti, et al.
Published: (2022-01-01)
Attitudes towards Chagas' disease in an endemic Brazilian community Crenças populares relativas à doença de Chagas em uma comunidade de área endêmica do Brasil
by: Sarah Williams-Blangero, et al.
Published: (1999-01-01)
by: Sarah Williams-Blangero, et al.
Published: (1999-01-01)
Panniculitis in reactivation of Chagas disease in a cardiac transplant patient
by: Gabriela T. Batiston, et al.
Published: (2024-01-01)
by: Gabriela T. Batiston, et al.
Published: (2024-01-01)
Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against <i>Trypanosoma cruzi</i>: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease
by: Leonardo da Silva Lara, et al.
Published: (2022-05-01)
by: Leonardo da Silva Lara, et al.
Published: (2022-05-01)
Immunopathological Mechanisms Underlying Cardiac Damage in Chagas Disease
by: Mariana Citlalli De Alba-Alvarado, et al.
Published: (2023-02-01)
by: Mariana Citlalli De Alba-Alvarado, et al.
Published: (2023-02-01)
Parasitological cure of Chagas disease: is it possible? Is it relevant?
by: Urbina Julio A
Published: (1999-01-01)
by: Urbina Julio A
Published: (1999-01-01)
Progress towards interruption of transmission of Chagas disease
by: Alvaro Moncayo
Published: (1999-09-01)
by: Alvaro Moncayo
Published: (1999-09-01)
Parasitological cure of Chagas disease: is it possible? Is it relevant?
by: Julio A Urbina
Published: (1999-09-01)
by: Julio A Urbina
Published: (1999-09-01)
Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
by: Carlos Henrique Lima Imperador, et al.
Published: (2022-05-01)
by: Carlos Henrique Lima Imperador, et al.
Published: (2022-05-01)
Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease
by: Carolina Cattoni Koh, et al.
Published: (2023-01-01)
by: Carolina Cattoni Koh, et al.
Published: (2023-01-01)
Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease
by: Amanda Fortes Francisco, et al.
Published: (2023-11-01)
by: Amanda Fortes Francisco, et al.
Published: (2023-11-01)
Epidemiologia de um caso de doença de Chagas na Ilha do Mosqueiro - Pará
by: Adelson A.A. de Souza, et al.
Published: (1988-12-01)
by: Adelson A.A. de Souza, et al.
Published: (1988-12-01)
The role of the immune response on the development of severe clinical forms of human Chagas disease
by: Rodrigo Corrêa-Oliveira, et al.
Published: (1999-09-01)
by: Rodrigo Corrêa-Oliveira, et al.
Published: (1999-09-01)
The End Justifies the Means: Chagas Disease from a Perspective of the Host–<i>Trypanosoma cruzi</i> Interaction
by: Izadora Volpato Rossi, et al.
Published: (2024-04-01)
by: Izadora Volpato Rossi, et al.
Published: (2024-04-01)
Epidemiology of Chagas Disease in the United States of America: A Short Review and Some Comments
by: Stephen A. Klotz
Published: (2025-01-01)
by: Stephen A. Klotz
Published: (2025-01-01)
Discovery of New Hits as Antitrypanosomal Agents by In Silico and In Vitro Assays Using Neolignan-Inspired Natural Products from <i>Nectandra leucantha</i>
by: Sheila C. Araujo, et al.
Published: (2021-07-01)
by: Sheila C. Araujo, et al.
Published: (2021-07-01)
Criteria of Chagas disease cure
by: J Romeu Cançado
Published: (1999-09-01)
by: J Romeu Cançado
Published: (1999-09-01)
Criteria of Chagas disease cure
by: Cançado J Romeu
Published: (1999-01-01)
by: Cançado J Romeu
Published: (1999-01-01)
Estudo da fauna de triatomíneos e da ocorrência de doença de Chagas em Monte Negro, Rondônia, Brasil Study of the triatomine fauna and occurrence of Chagas disease in Monte Negro, Rondonia, Brazil
by: Débora Cristina Massaro, et al.
Published: (2008-06-01)
by: Débora Cristina Massaro, et al.
Published: (2008-06-01)
Using a Chagas disease hospital database: a clinical and epidemiological patient profile
by: Andressa Bruscato, et al.
by: Andressa Bruscato, et al.
Trypanosoma cruzi I genotype among isolates from patients with chronic Chagas disease followed at the Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ, Brazil)
by: Tatiana da Silva Fonseca de Oliveira, et al.
by: Tatiana da Silva Fonseca de Oliveira, et al.
Understanding Host–Pathogen Interactions in Congenital Chagas Disease Through Transcriptomic Approaches
by: Tatiana M. Cáceres, et al.
Published: (2025-01-01)
by: Tatiana M. Cáceres, et al.
Published: (2025-01-01)
Acute Pediatric Chagas Disease in Antioquia, Colombia: A Geographic Location of Suspected Oral Transmission
by: Lídia Gual-Gonzalez, et al.
Published: (2021-12-01)
by: Lídia Gual-Gonzalez, et al.
Published: (2021-12-01)
The Functions of Cytokines in the Cardiac Immunopathogenesis of Chagas Disease
by: Mariana Citlalli de Alba-Alvarado, et al.
Published: (2024-10-01)
by: Mariana Citlalli de Alba-Alvarado, et al.
Published: (2024-10-01)
Influencia de la inoculación oral en la enfermedad de Chagas en modelo murino
by: Oscar A. Reboreda-Hernandez, et al.
Published: (2021-03-01)
by: Oscar A. Reboreda-Hernandez, et al.
Published: (2021-03-01)
Similar Items
-
Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models
by: Lorraine Martins Rocha Orlando, et al.
Published: (2023-09-01) -
Evaluation of the Chagas Western Blot IgG Assay for the Diagnosis of Chagas Disease
by: Jean-Yves Brossas, et al.
Published: (2021-11-01) -
An Update on Vaccines Against <i>Trypanosoma cruzi</i> and Chagas Disease
by: Nisha J. Garg
Published: (2025-01-01) -
Chagas, a lógica e a descoberta Chagas, the logic and the discovery
by: François Delaporte
Published: (1995-02-01) -
In Vitro Antioxidant and Antitrypanosomal Activities of Extract and Fractions of <i>Terminalia catappa</i>
by: Sandra Alves de Araújo, et al.
Published: (2023-06-01)
